Cytori Therapeutics (CYTX) Balance Sheet

Click line-items for a historical chart and %

Cash and cash equivalents	12.56M
Accounts receivable, net of reserves of $349,000 and $306,000 in 2011 and 2010, respectively	1.24M
Inventories, net	3.73M
Other current assets	870K
Total current assets	18.75M
Property and equipment, net	1.16M
Restricted cash and cash equivalents	0
Investment in joint venture
Other assets	2.34M
Intangibles, net	8.45M
Goodwill	3.92M
Total assets	34.61M
Accounts payable and accrued expenses	5.87M
Current portion of long-term obligations	6.63M
Total current liabilities	12.5M
Deferred revenues, related party
Deferred revenues	97K
Warrant liability
Option liability
Long-term deferred rent	17K
Long-term obligations, net of discount, less current portion	11.01M
Total liabilities	23.62M
Commitments and contingencies	0
Preferred stock, $0.001 par value; 5,000,000 shares authorized; -0- shares issued and outstanding in 2011 and 2010	0
Common stock, $0.001 par value; 95,000,000 shares authorized; 52,470,226 and 51,955,265 shares issued and 52,470,226 and 51,955,265 shares outstanding in 2011 and 2010, respectively	22K
Additional paid-in capital	388.77M
Accumulated deficit	-379.06M
Total stockholders' equity	10.99M
Total liabilities and stockholders' equity	34.61M

Entities mentioned with CYTX

View All Entities